Literature DB >> 17845376

Economic burden of a gluten-free diet.

A R Lee1, D L Ng, J Zivin, P H R Green.   

Abstract

BACKGROUND: Coeliac disease is a common, autoimmune disorder, for which the only treatment is lifelong adherence to a gluten-free diet. This study evaluates the economic burden of adhering to a gluten-free diet.
METHODS: A market basket of products identified by name brand, weight or package size for both regular wheat-based products and gluten-free counterparts was developed. The differences in price between purchase venues, both type of store (general grocery store, an upscale grocery store and a health food store and four internet-based grocery sites) and region was also analysed.
RESULTS: Availability of gluten-free products varied between the different venues, regular grocery stores carried 36%, while upscale markets carried 41%, and health food stores 94%, compared with 100% availability on the internet. Overall, every gluten-free product was more expensive than their wheat-based counterpart (P <or= 0.05). Bread and pasta was twice as expensive as their wheat-based counterparts. Cost was affected more by shopping venue than geographic location.
CONCLUSIONS: This study demonstrated that gluten-free foods have poor availability and are more expensive than their gluten-containing counterparts. The impact of these findings on dietary compliance and the quality of life needs to be addressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17845376     DOI: 10.1111/j.1365-277X.2007.00763.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  75 in total

1.  Adherence to gluten-free diet and barriers to adherence in patients with celiac disease.

Authors:  Preeti Rajpoot; Aishwairya Sharma; S Harikrishnan; Bhaskar J Baruah; Vineet Ahuja; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2015-11-18

2.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

3.  New and developing therapies for celiac disease.

Authors:  Christina A Tennyson; Suzanne K Lewis; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

Review 4.  Nonceliac Gluten Sensitivity.

Authors:  Anna Krigel; Benjamin Lebwohl
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 5.  A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.

Authors:  Brian P McAllister; Emmanuelle Williams; Kofi Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

6.  Chronic disease self-management within the monthly benefit cycle of the Supplemental Nutrition Assistance Program.

Authors:  Eliza Whiteman Kinsey; Roxanne Dupuis; Megan Oberle; Carolyn C Cannuscio; Amy Hillier
Journal:  Public Health Nutr       Date:  2019-05-20       Impact factor: 4.022

Review 7.  Screening for celiac disease in the general population and in high-risk groups.

Authors:  Jonas F Ludvigsson; Timothy R Card; Katri Kaukinen; Julio Bai; Fabiana Zingone; David S Sanders; Joseph A Murray
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 8.  The spectrum of noncoeliac gluten sensitivity.

Authors:  Imran Aziz; Marios Hadjivassiliou; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

9.  The unfolding story of celiac disease risk factors.

Authors:  Benjamin Lebwohl; Jonas F Ludvigsson; Peter H R Green
Journal:  Clin Gastroenterol Hepatol       Date:  2013-11-07       Impact factor: 11.382

10.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.